First Time Loading...

Prometheus Biosciences Inc
NASDAQ:RXDX

Watchlist Manager
Prometheus Biosciences Inc Logo
Prometheus Biosciences Inc
NASDAQ:RXDX
Watchlist
Price: 199.92 USD 0.09% Market Closed
Updated: May 20, 2024

EV/EBITDA
Enterprise Value to EBITDA

-54.6
Current
-22.8
Median
4.6
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-54.6
=
Enterprise Value
8.8B
/
EBITDA
-161.6m
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-43.6
2-Years Forward
EV/EBITDA
-37.1
3-Years Forward
EV/EBITDA
-31.6

See Also

Discover More